The Inspectorate of Public Health, Social Development and Labor informs the public that there is a recall for medications containing the active ingredient ranitidine.
This recall has been issued following indications of the possible presence of an undesirable substance N-nitrosodimethylamine (NDMA) in the medicines containing ranitidine. As a precautionary measure the ranitidine containing medicines are recalled on a pharmacy and patient level.
Pharmacies and pharmaceutical distributors were therefore instructed to remove the affected medications from their stock and quarantine them. In addition pharmacies were instructed to contact all known patients currently using ranitidine.
Patients taking ranitidine medication affected by this recall are advised to return the affected medicines to the pharmacy and contact their doctor or healthcare professional who can advise on an alternative treatment.
Dr. E. Best, Inspector General VSA.
October 9, 201
